{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T19:53:32Z","timestamp":1780084412912,"version":"3.54.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T00:00:00Z","timestamp":1581724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T00:00:00Z","timestamp":1581724800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"a National Research Foundation (NRF) grant funded by the Ministry of Education, Science and Technology (MEST) in Korea","award":["NRF-2018R1C1B3008971"],"award-info":[{"award-number":["NRF-2018R1C1B3008971"]}]},{"name":"clinical research grant-in-aid from the Seoul Metropolitan Government Seoul National University (SMG-SNU) Boramae Medical Center","award":["03-2015-8"],"award-info":[{"award-number":["03-2015-8"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10072-020-04289-6","type":"journal-article","created":{"date-parts":[[2020,2,15]],"date-time":"2020-02-15T06:25:56Z","timestamp":1581747956000},"page":"1837-1842","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Contrast sensitivity impairment in drug-na\u00efve Parkinson\u2019s disease patients associates with early cognitive decline"],"prefix":"10.1007","volume":"41","author":[{"given":"Sang Bin","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeeyun","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalla","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Young","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beomseok","family":"Jeon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9120-2075","authenticated-orcid":false,"given":"Jee-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,15]]},"reference":[{"key":"4289_CR1","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, Leurgans S, LeWitt PA, Nyenhuis D, Olanow CW, Rascol O, Schrag A, Teresi JA, van Hilten JJ, LaPelle N, Movement Disorder Society UPDRS Revision Task Force (2008) Movement Disorder Society-sponsored revision of the unified Parkinson\u2019s disease rating scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord Off J Mov Disord Soc 23:2129\u20132170","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"4289_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1002\/mds.24996","volume":"27","author":"RB Postuma","year":"2012","unstructured":"Postuma RB, Aarsland D, Barone P, Burn DJ, Hawkes CH, Oertel W, Ziemssen T (2012) Identifying prodromal Parkinson\u2019s disease: pre-motor disorders in Parkinson\u2019s disease. Mov Disord 27:617\u2013626","journal-title":"Mov Disord"},{"key":"4289_CR3","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","volume":"5","author":"KR Chaudhuri","year":"2006","unstructured":"Chaudhuri KR, Healy DG, Schapira AH (2006) Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management. Lancet Neurol 5:235\u2013245","journal-title":"Lancet Neurol"},{"key":"4289_CR4","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00702-009-0292-z","volume":"116","author":"I Bodis-Wollner","year":"2009","unstructured":"Bodis-Wollner I (2009) Retinopathy in Parkinson disease. J Neural Transm 116:1493","journal-title":"J Neural Transm"},{"key":"4289_CR5","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1212\/WNL.36.8.1121","volume":"36","author":"C Bulens","year":"1986","unstructured":"Bulens C, Meerwaldt JD, van der Wildt GJ, Keemink CJ (1986) Contrast sensitivity in Parkinson\u2019s disease. Neurology 36:1121\u20131125","journal-title":"Neurology"},{"key":"4289_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0022-510X(99)00204-X","volume":"172","author":"V Pieri","year":"2000","unstructured":"Pieri V, Diederich NJ, Raman R, Goetz CG (2000) Decreased color discrimination and contrast sensitivity in Parkinson\u2019s disease. J Neurol Sci 172:7\u201311. https:\/\/doi.org\/10.1016\/S0022-510X(99)00204-X","journal-title":"J Neurol Sci"},{"key":"4289_CR7","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1212\/WNL.42.4.887","volume":"42","author":"MJM Price","year":"1992","unstructured":"Price MJM, Feldman RG, Adelberg D, Kayne H (1992) Abnormalities in color vision and contrast sensitivity in Parkinson\u2019s disease. Neurology. 42:887\u2013890","journal-title":"Neurology."},{"key":"4289_CR8","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1001\/archneur.1993.00540070041012","volume":"50","author":"JT Hutton","year":"1993","unstructured":"Hutton JT, Morris JL, Elias JW (1993) Levodopa improves spatial contrast sensitivity in Parkinson\u2019s disease. Arch Neurol 50:721\u2013724","journal-title":"Arch Neurol"},{"key":"4289_CR9","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/mds.870070308","volume":"7","author":"RD Jones","year":"1992","unstructured":"Jones RD, Donaldson IM, Timmings PL (1992) Impairment of high-contrast visual acuity in Parkinson\u2019s disease. Mov Disord 7:232\u2013238. https:\/\/doi.org\/10.1002\/mds.870070308","journal-title":"Mov Disord"},{"key":"4289_CR10","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1136\/bjo.62.4.198","volume":"62","author":"GB Arden","year":"1978","unstructured":"Arden GB (1978) The importance of measuring contrast sensitivity in cases of visual disturbance. Br J Ophthalmol 62:198\u2013209","journal-title":"Br J Ophthalmol"},{"key":"4289_CR11","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/ana.25196","volume":"83","author":"ME Ward","year":"2018","unstructured":"Ward ME, Gelfand JM, Lui L-Y, Ou Y, Green AJ, Stone K, Pedula KL, Cummings SR, Yaffe K (2018) Reduced contrast sensitivity among older women is associated with increased risk of cognitive impairment. Ann Neurol 83:730\u2013738. https:\/\/doi.org\/10.1002\/ana.25196","journal-title":"Ann Neurol"},{"key":"4289_CR12","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1097\/WNO.0b013e31828c4e1a","volume":"33","author":"CR Adam","year":"2013","unstructured":"Adam CR, Shrier E, Ding Y, Glazman S, Bodis-Wollner I (2013) Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease. J Neuroophthalmol 33:137\u2013142. https:\/\/doi.org\/10.1097\/WNO.0b013e31828c4e1a","journal-title":"J Neuroophthalmol"},{"key":"4289_CR13","first-page":"289","volume":"21","author":"NJ Diederich","year":"1998","unstructured":"Diederich NJ, Goetz CG, Raman R, Pappert EJ, Leurgans S, Piery V (1998) Poor visual discrimination and visual hallucinations in Parkinson\u2019s disease. Clin Neuropharmacol 21:289\u2013295","journal-title":"Clin Neuropharmacol"},{"key":"4289_CR14","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/mds.25543","volume":"29","author":"J-Y Lee","year":"2014","unstructured":"Lee J-Y, Kim JM, Ahn J, Kim H-J, Jeon BS, Kim TW (2014) Retinal nerve fiber layer thickness and visual hallucinations in Parkinson\u2019s disease. Mov Disord Off J Mov Disord Soc 29:61\u201367. https:\/\/doi.org\/10.1002\/mds.25543","journal-title":"Mov Disord Off J Mov Disord Soc"},{"key":"4289_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1136\/bjo.88.1.11","volume":"88","author":"K Pesudovs","year":"2004","unstructured":"Pesudovs K, Hazel CA, Doran RML, Elliott DB (2004) The usefulness of Vistech and FACT contrast sensitivity charts for cataract and refractive surgery outcomes research. Br J Ophthalmol 88:11\u201316. https:\/\/doi.org\/10.1136\/bjo.88.1.11","journal-title":"Br J Ophthalmol"},{"key":"4289_CR16","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nrn3743","volume":"15","author":"TA LeGates","year":"2014","unstructured":"LeGates TA, Fernandez DC, Hattar S (2014) Light as a central modulator of circadian rhythms, sleep and affect. Nat Rev Neurosci 15:443\u2013454. https:\/\/doi.org\/10.1038\/nrn3743","journal-title":"Nat Rev Neurosci"},{"key":"4289_CR17","doi-asserted-by":"publisher","first-page":"14989","DOI":"10.1523\/JNEUROSCI.2039-13.2013","volume":"33","author":"CK Hwang","year":"2013","unstructured":"Hwang CK, Chaurasia SS, Jackson CR, Chan GC-K, Storm DR, Iuvone PM (2013) Circadian rhythm of contrast sensitivity is regulated by a dopamine-neuronal PAS-domain protein 2-adenylyl cyclase 1 signaling pathway in retinal ganglion cells. J Neurosci 33:14989\u201314997. https:\/\/doi.org\/10.1523\/JNEUROSCI.2039-13.2013","journal-title":"J Neurosci"},{"key":"4289_CR18","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1152\/jn.00635.2016","volume":"117","author":"JE Niemeyer","year":"2017","unstructured":"Niemeyer JE, Paradiso MA (2017) Contrast sensitivity, V1 neural activity, and natural vision. J Neurophysiol 117:492\u2013508. https:\/\/doi.org\/10.1152\/jn.00635.2016","journal-title":"J Neurophysiol"},{"key":"4289_CR19","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/0042-6989(90)90066-T","volume":"30","author":"D Elliott","year":"1990","unstructured":"Elliott D, Whitaker D, MacVeigh D (1990) Neural contribution to spatiotemporal contrast sensitivity decline in healthy ageing eyes. Vis Res 30:541\u2013547. https:\/\/doi.org\/10.1016\/0042-6989(90)90066-T","journal-title":"Vis Res"},{"key":"4289_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.parkreldis.2016.10.006","volume":"34","author":"A Ridder","year":"2017","unstructured":"Ridder A, M\u00fcller MLTM, Kotagal V, Frey KA, Albin RL, Bohnen NI (2017) Impaired contrast sensitivity is associated with more severe cognitive impairment in Parkinson disease. Parkinsonism Relat Disord 34:15\u201319. https:\/\/doi.org\/10.1016\/j.parkreldis.2016.10.006","journal-title":"Parkinsonism Relat Disord"},{"key":"4289_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/13825580802233418","volume":"16","author":"E Moes","year":"2009","unstructured":"Moes E, Lombardi KM (2009) The relationship between contrast sensitivity, gait, and reading speed in Parkinson\u2019s disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn 16:121\u2013132. https:\/\/doi.org\/10.1080\/13825580802233418","journal-title":"Neuropsychol Dev Cogn B Aging Neuropsychol Cogn"},{"key":"4289_CR22","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1167\/iovs.16-20460","volume":"58","author":"M Satue","year":"2017","unstructured":"Satue M, Rodrigo MJ, Obis J, Vilades E, Gracia H, Otin S, Fuertes MI, Alarcia R, Crespo JA, Polo V, Larrosa JM, Pablo LE, Garcia-Martin E (2017) Evaluation of progressive visual dysfunction and retinal degeneration in patients with Parkinson\u2019s disease. Investig Opthalmol Vis Sci 58:1151. https:\/\/doi.org\/10.1167\/iovs.16-20460","journal-title":"Investig Opthalmol Vis Sci"},{"key":"4289_CR23","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/eye.2017.23","volume":"31","author":"V Polo","year":"2017","unstructured":"Polo V, Rodrigo MJ, Garcia-Martin E, Otin S, Larrosa JM, Fuertes MI, Bambo MP, Pablo LE, Satue M (2017) Visual dysfunction and its correlation with retinal changes in patients with Alzheimer\u2019s disease. Eye. 31:1034\u20131041. https:\/\/doi.org\/10.1038\/eye.2017.23","journal-title":"Eye."},{"key":"4289_CR24","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1002\/mds.27392","volume":"33","author":"I Ortu\u00f1o-Lizar\u00e1n","year":"2018","unstructured":"Ortu\u00f1o-Lizar\u00e1n I, Beach TG, Serrano GE, Walker DG, Adler CH, Cuenca N (2018) Phosphorylated \u03b1-synuclein in the retina is a biomarker of Parkinson\u2019s disease pathology severity. Mov Disord 33:1315\u20131324. https:\/\/doi.org\/10.1002\/mds.27392","journal-title":"Mov Disord"},{"key":"4289_CR25","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/mp.2016.251","volume":"22","author":"TM Shah","year":"2017","unstructured":"Shah TM, Gupta SM, Chatterjee P, Campbell M, Martins RN (2017) Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer\u2019s disease. Mol Psychiatry 22:353\u2013363. https:\/\/doi.org\/10.1038\/mp.2016.251","journal-title":"Mol Psychiatry"},{"key":"4289_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2015.11.018","volume":"22","author":"A Lenka","year":"2016","unstructured":"Lenka A, Hegde S, Jhunjhunwala KR, Pal PK (2016) Interactions of visual hallucinations, rapid eye movement sleep behavior disorder, and cognitive impairment in Parkinson\u2019s disease: a review. Parkinsonism Relat Disord 22:1\u20138. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.11.018","journal-title":"Parkinsonism Relat Disord"},{"key":"4289_CR27","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s11910-017-0738-x","volume":"17","author":"S-M Fereshtehnejad","year":"2017","unstructured":"Fereshtehnejad S-M, Postuma RB (2017) Subtypes of Parkinson\u2019s disease: what do they tell us about disease progression? Curr Neurol Neurosci Rep 17:34\u201310. https:\/\/doi.org\/10.1007\/s11910-017-0738-x","journal-title":"Curr Neurol Neurosci Rep"},{"key":"4289_CR28","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1002\/mds.22506","volume":"24","author":"J Kulisevsky","year":"2009","unstructured":"Kulisevsky J, Pagonabarraga J (2009) Cognitive impairment in Parkinson\u2019s disease: tools for diagnosis and assessment. Mov Disord 24:1103\u20131110. https:\/\/doi.org\/10.1002\/mds.22506","journal-title":"Mov Disord"},{"key":"4289_CR29","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.jcrs.2013.05.001","volume":"39","author":"J Richman","year":"2013","unstructured":"Richman J, Spaeth GL, Wirostko B (2013) Contrast sensitivity basics and a critique of currently available tests. J Cataract Refract Surg 39:1100\u20131106. https:\/\/doi.org\/10.1016\/j.jcrs.2013.05.001","journal-title":"J Cataract Refract Surg"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04289-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-020-04289-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04289-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,14]],"date-time":"2021-02-14T10:04:05Z","timestamp":1613297045000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-020-04289-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,15]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["4289"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04289-6","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,15]]},"assertion":[{"value":"6 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"SB Hong, J.-Y. Lee, J. Ahn, D Yoo, JY Shin, and B. Jeon report there are no potential conflict of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}